CNBC Television Jim Cramer’s lightning round: I like Amarin stock here
🎯 Загружено автоматически через бота:
🚫 Оригинал видео:
📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал.
✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его.
📃 Оригинальное описание:
“Mad Money“ host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Enterprise Products Partners: “I could hold, but I’ve got to tell you I don’t like that group one bit. It’s been really terrible. There’s a lot of competition coming in there and those stocks are bad.”
Amarin Corporation: “I like it here.”
Global Blood Therapeutics: “I’m giving it my blessing.”
Ball Corporation: “I like that. There’s been some consolidation in that industry and the gas industry. ... I like Ball Corp.”
Albemarle Corp.: “I did like it. The specialty chemical stocks they are kind of counter cyclical. Right now every chemical stock is going down and I’m not going to stick my head” in that.
Exact Sciences: They’re not doing enough right now.
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:
#CNBC
#CNBC TV
5 views
0
0
1 week ago 00:01:20 1
[CNBC Television] BlackRock CEO Larry Fink says bitcoin impacts the U.S. dollar
1 week ago 00:01:39 1
[CNBC Television] Moderna’s phase three RSV trial found to be 83.7% effective in older adults
1 week ago 00:03:43 1
[CNBC Television] We could be approaching an earnings recession: Investment strategist
1 week ago 00:04:09 1
[CNBC Television] Blackstone enters deal to manage AIG’s insurance and housing assets
1 week ago 00:03:07 1
[CNBC Television] Two strategists break down markets ahead of busy earnings week, FOMC meeting
1 week ago 00:01:49 1
[CNBC Television] Small businesses push back on Amazon Prime Day
1 week ago 00:19:11 1
[CNBC Television] ETF Edge, November 11, 2024
1 week ago 00:01:29 1
[CNBC Television] Popular American SUVs to be hit by Mexico tariffs
1 week ago 00:03:48 1
[CNBC Television] Inflation battle is ’absolutely’ done, says Yardeni Research president
1 week ago 00:01:48 1
[CNBC Television] Final Trades: Apple, Oracle, Roku & more
1 week ago 00:01:19 1
[CNBC Television] CNBC Millionaire Survey: 42% expect the economy to be weaker in 2024
1 week ago 00:05:14 1
[CNBC Television] Look for companies with better balance sheets: Pro
1 week ago 00:06:13 1
[CNBC Television] Cyclicals are going to be a winner: Jonathan Golub